| Biotechnology Industry | Healthcare Sector | Dr. Jing Zhao Ph.D. CEO | SSE Exchange | CNE100005964 ISIN |
| CN Country | 1,506 Employees | 9 Jun 2026 Last Dividend | - Last Split | - IPO Date |
GemPharmatech Co., Ltd. is a reputable contract research organization that specializes in providing a broad range of genetically engineered mouse models alongside comprehensive preclinical research services to the global scientific community. Established in 2017 and with its headquarters located in Nanjing, China, the company has quickly become a pivotal player in facilitating the progress of scientific research and drug development through its innovative solutions and expert services. GemPharmatech's clientele spans across various sectors within the scientific community, underscoring its commitment to advancing research and development in the life sciences.
The company offers an extensive array of mouse models to cater to different research needs. This includes knockout and conditional knockout models for studying gene function, disease mouse models for researching various pathologies, immunodeficient mice for immunology and cancer research, germ-free mice for gut microbiome studies, and tool mice models for a broad range of experimental applications. Additionally, GemPharmatech operates a wild mouse project, contributing to the diversity and applicability of its mouse model offerings.
For researchers requiring specific genetic modifications in mice, GemPharmatech provides custom model generation services. This tailored service enables precise alterations in mouse genomes to create unique models that suit specific experimental requirements, thereby facilitating targeted research and discovery processes.
To support drug development processes, the company delivers comprehensive preclinical testing services. These tests evaluate the safety and efficacy of new compounds or treatments in animal models, providing essential data before clinical trials in humans can commence.
Apart from supplying germ-free mice, GemPharmatech offers services exploring the microbiome's impact on health and disease. This includes not only the provision of germ-free models but also customized research services involving the microbiome, catering to this rapidly expanding field of study.
Understanding the need for varied biological systems in research, the company also provides cell lines along with customization services. This enables the cultivation and manipulation of specific cell types for in vitro studies, complementing the in vivo research conducted with mouse models.
To ensure researchers have access to the necessary genetic backgrounds and quantities of mice for their studies, GemPharmatech offers custom breeding services. This service allows for the production of specific mouse lines under controlled conditions, catering to extensive and complex experimental setups.
Maintaining high standards of research integrity and accuracy, the company provides animal quality testing services. This includes health monitoring, genetic testing, and pathogen testing to ensure the animals used in research are of the highest quality and suitable for the intended studies.
In addition to the aforementioned services, GemPharmatech offers a range of other ancillary services to facilitate and enhance research outcomes. These services are designed to meet the varied needs of the scientific community, ensuring comprehensive support for their research endeavors.